HK1032953A1 - Indole derivatives useful a.o. for the treatment of osteoporosis. - Google Patents

Indole derivatives useful a.o. for the treatment of osteoporosis.

Info

Publication number
HK1032953A1
HK1032953A1 HK01101878A HK01101878A HK1032953A1 HK 1032953 A1 HK1032953 A1 HK 1032953A1 HK 01101878 A HK01101878 A HK 01101878A HK 01101878 A HK01101878 A HK 01101878A HK 1032953 A1 HK1032953 A1 HK 1032953A1
Authority
HK
Hong Kong
Prior art keywords
osteoporosis
treatment
indole derivatives
derivatives useful
useful
Prior art date
Application number
HK01101878A
Other languages
English (en)
Inventor
Stefania Gagliardi
Guy Marguerite Marie Ge Nadler
Pietro Novella
Original Assignee
Smithkline Beecham Spa
Smithkline Beecham Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Spa, Smithkline Beecham Lab filed Critical Smithkline Beecham Spa
Publication of HK1032953A1 publication Critical patent/HK1032953A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK01101878A 1997-12-24 2001-03-15 Indole derivatives useful a.o. for the treatment of osteoporosis. HK1032953A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97403154 1997-12-24
PCT/EP1998/008561 WO1999033822A1 (en) 1997-12-24 1998-12-17 Indole derivatives useful a.o. for the treatment of osteoporosis

Publications (1)

Publication Number Publication Date
HK1032953A1 true HK1032953A1 (en) 2001-08-10

Family

ID=8229937

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101878A HK1032953A1 (en) 1997-12-24 2001-03-15 Indole derivatives useful a.o. for the treatment of osteoporosis.

Country Status (23)

Country Link
EP (1) EP1042316B1 (es)
JP (1) JP4627881B2 (es)
KR (1) KR20010033528A (es)
CN (1) CN1208333C (es)
AR (1) AR018032A1 (es)
AT (1) ATE288909T1 (es)
AU (1) AU749319B2 (es)
BR (1) BR9814403A (es)
CA (1) CA2315723A1 (es)
CO (1) CO4970811A1 (es)
DE (1) DE69828998T2 (es)
ES (1) ES2236971T3 (es)
HK (1) HK1032953A1 (es)
HU (1) HUP0100785A3 (es)
IL (1) IL136720A0 (es)
NO (1) NO320272B1 (es)
NZ (1) NZ505060A (es)
PL (1) PL191633B1 (es)
SA (1) SA99200109B1 (es)
SI (1) SI1042316T1 (es)
TR (1) TR200001992T2 (es)
WO (1) WO1999033822A1 (es)
ZA (1) ZA9811758B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) * 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
GB9914825D0 (en) * 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
US6872834B2 (en) 2000-03-31 2005-03-29 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted indoles and indazoles
WO2001074815A2 (en) 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. Phenyl-substituted imidazopyridines
EP1268421B1 (en) * 2000-03-31 2009-05-06 Ortho-McNeil Pharmaceutical, Inc. Phenyl-substituted indoles as histamine h3-receptor antagonists
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
US20090142832A1 (en) 2007-11-29 2009-06-04 James Dalton Indoles, Derivatives, and Analogs Thereof and Uses Therefor
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
CA2965472C (en) 2014-10-24 2021-08-24 Josep Bassaganya-Riera Lanthionine synthetase c-like 2-based therapeutics
EP3717633A1 (en) 2017-11-30 2020-10-07 Landos Biopharma, Inc. Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith
JP7430852B2 (ja) 2019-12-20 2024-02-14 エヌイミューン バイオファーマ インコーポレイテッド ランチオニンｃ様タンパク質２リガンド、それを用いて調製される細胞、およびそれを使用する療法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3542827B2 (ja) * 1994-07-15 2004-07-14 帝国臓器製薬株式会社 新規な５−置換イソキサゾール−３−カルボン酸アミド誘導体
AU4536096A (en) * 1995-01-10 1996-07-31 Smithkline Beecham Spa Indole derivatives useful in the treatment of osteoporosis
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
AU757059B2 (en) * 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto

Also Published As

Publication number Publication date
NO320272B1 (no) 2005-11-14
AR018032A1 (es) 2001-10-31
HUP0100785A2 (hu) 2001-08-28
DE69828998T2 (de) 2006-05-04
ZA9811758B (en) 2000-06-22
HUP0100785A3 (en) 2001-09-28
JP4627881B2 (ja) 2011-02-09
ES2236971T3 (es) 2005-07-16
PL191633B1 (pl) 2006-06-30
NO20003315L (no) 2000-06-23
CN1208333C (zh) 2005-06-29
AU749319B2 (en) 2002-06-20
CO4970811A1 (es) 2000-11-07
DE69828998D1 (de) 2005-03-17
EP1042316A1 (en) 2000-10-11
KR20010033528A (ko) 2001-04-25
BR9814403A (pt) 2000-10-10
ATE288909T1 (de) 2005-02-15
NZ505060A (en) 2002-09-27
EP1042316B1 (en) 2005-02-09
WO1999033822A1 (en) 1999-07-08
AU2715499A (en) 1999-07-19
TR200001992T2 (tr) 2001-01-22
CA2315723A1 (en) 1999-07-08
CN1299357A (zh) 2001-06-13
SA99200109B1 (ar) 2006-09-13
NO20003315D0 (no) 2000-06-23
JP2003532616A (ja) 2003-11-05
IL136720A0 (en) 2001-06-14
PL341318A1 (en) 2001-04-09
SI1042316T1 (es) 2005-08-31

Similar Documents

Publication Publication Date Title
ZA988078B (en) Substituted oxindole derivatives.
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
ZA9811898B (en) Anti-Inflammatory Compounds.
ZA98970B (en) N-hydroxy-ß-sulfonyl propionamide derivatives.
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
AU1139095A (en) Combination treatment for osteoporosis
HUP9801168A3 (en) Triazinylaminostilbene derivatives
ZA961697B (en) Indole derivatives.
GB9908648D0 (en) Substituted thienobenzisoxazole derivatives for enhancing cognition
GB2341180A9 (en) Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds
ZA973209B (en) Therapeutic compounds.
IL136720A0 (en) Indole derivatives useful a.o. for the treatment of osteoporosis
ZA9810033B (en) Process for the preparation of Thiazolidinedione Derivatives.
AU7450898A (en) Indole compounds
ZA974811B (en) Novel therapeutic compounds.
ZA982436B (en) Thiazolimine derivatives.
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB9908644D0 (en) Substituted thienylcyclohexanone derivatives for enhancing cognition
ZA98495B (en) 5-Aroylnaphthalene derivatives
ZA982255B (en) Process for the preparation of arylmalonates.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081217